Plain-English translation of NCT07572396 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
Hong Kong
Phase
Testing effectiveness
Sponsor
Amplexd Therapeutics, Inc.
Collaborators
Prince of Wales Hospital, Shatin, Hong Kong, Chinese University of Hong Kong
Enrollment target
~45 participants
Started
April 2026
Primary completion
December 2026
Age range
18 Years – 65 Years
Sex
Female only
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Trial Manager
Prince of Wales Hospital, Chinese University of Hong Kong
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.